On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...